Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FXD vs FXH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FXH Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

FXH Overall Winner 6-Pillar Tally: FXD 0 – 0 FXH (6 Tie) Matrix Metrics: FXD 0 – 3 FXH

As of Nov 16, 2026, First Trust Health Care AlphaDEX Fund (FXH) is the stronger overall head-to-head candidate over First Trust Consumer Discretionary AlphaDEX Fund (FXD) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FXD carries a Unified Composite Score of 40.7/100 (SELL) at $69.86 (N/M Forward P/E, N/A operating margin), whereas FXH carries 48.7/100 (HOLD) at $136.68 (N/M Forward P/E, N/A operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FXD vs FXH
FXD NYSE Arca
First Trust Consumer Discretionary AlphaDEX Fund
Institutional Equity
$69.86
-0.99% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.76β · 33% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 37.0 Fund 41.0 Flow 50.0 Mom 41.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 55
RSI-14: 54.8 · SMA20: $69.32 · SMA50: $66.93
FXH NYSE Arca Head-to-Head Winner
First Trust Health Care AlphaDEX Fund
Institutional Equity
$136.68
-1.11% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.57β · 25% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.3% over 20 days), RSI 53
RSI-14: 52.7 · SMA20: $137.44 · SMA50: $133.45

6-Pillar Scorecard Institutional Category Breakdown (FXD 0 – 0 FXH)

Columns: Metric · FXD · FXH
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 23.8% (100th %ile) 22.8% (85th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FXD (0) vs FXH (3)
Institutional Metric FXD FXH Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
67% ($62–$74) 82% ($105–$144) Stronger Trend FXH
Beta / 30D Volatility
Risk Regime
0.76β · 33% Vol 0.57β · 25% Vol Lower Realized Risk FXH
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 48.7 / 100 (HOLD) Higher Composite FXH
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FXD +1.68 pp
FXD: +4.89% · FXH: +3.21%
3M Horizon FXH +2.99 pp
FXD: +0.48% · FXH: +3.47%
6M Horizon FXH +10.54 pp
FXD: +10.06% · FXH: +20.6%
1Y Horizon FXH +15.64 pp
FXD: +6.13% · FXH: +21.77%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FXD vs FXH. Trailing 12-month operating profitability (FXD N/A vs FXH N/A) and valuation multiples (FXD N/M vs FXH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

FXD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
FXH ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FXD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.8%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FXD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FXH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 22.8%
IV Percentile 85th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FXH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FXD Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
FXH Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ FXD vs FXH Key Questions & Quantitative Answers

As of Nov 16, 2026, First Trust Health Care AlphaDEX Fund (FXH) is the stronger overall head-to-head candidate over First Trust Consumer Discretionary AlphaDEX Fund (FXD) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FXD carries a Unified Composite Score of 40.7/100 (SELL) at $69.86 (N/M Forward P/E, N/A operating margin), whereas FXH carries 48.7/100 (HOLD) at $136.68 (N/M Forward P/E, N/A operating margin). Technically, FXD sits in a Neutral phase (RSI 54.8, UNCLASSIFIED options structure) and FXH sits in a Markup phase (RSI 52.7, UNCLASSIFIED options structure).

FXD and FXH split Growth & Scale metrics: FXD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with FXH at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FXD generates N/A in USD-normalized revenue versus N/A for FXH. In operating R&D and SG&A reinvestment, FXD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FXH.

FXD and FXH trade at balanced relative valuation multiples. FXD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas FXH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FXD (N/A ROE) versus FXH (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, FXD carries 23.8% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.76β · 33% Vol realized risk). By comparison, FXH carries 22.8% implied volatility (85th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.